VSee Health issues 40,000 shares to Clearthink in unregistered sale tied to $5 million equity line

• VSee Health executed a Strata Purchase Agreement with Clearthink Capital Partners for up to USD 5 million of common stock sales.
• Company will issue 40,000 common shares to Clearthink as a commitment fee in an unregistered transaction.
• Stock sales, if any, can be initiated by the company over about 36 months once a resale registration statement is effective.
• Purchase price set at 85% of the lowest daily close in the 10 trading days before each purchase date.
• Clearthink ownership capped at 9.99% of outstanding common stock under the agreement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VSee Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001185185-26-003896), on September 09, 2026, and is solely responsible for the information contained therein.